Moreover, in cystic fibrosis patients who underwent ivacaftor therapy, the HVCN1 mRNA expression was significantly higher than baseline at 1-3 months and decreased after 6 months of treatment (29). This evidence concerns the gene HVCN1 and cystic fibrosis.